Debate 1 – CML - Asciminib first line?

Activity: Invited talks and oral presentationsInvited Keynote and Plenary Presentations

Description

Highlight debate:
Chair: Andreas Hochhaus (Jena)
Audience votes
Affirmative Tim Hughes (Adelaide)
Negative Giuseppe Saglio (Turin)
Period7 Mar 20259 Mar 2025
Event titleEuropean School of Haematology (ESH): 4th How to Diagnose and Treat: CML/MPN Meeting 2025
Event typeConference
LocationVienna, AustriaShow on map
Degree of RecognitionInternational

Keywords

  • Asciminib
  • CML
  • treatment
  • clinical